BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nagachinta S, Bouzo BL, Vazquez-Rios AJ, Lopez R, Fuente M. Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics. Pharmaceutics 2020;12:E189. [PMID: 32098309 DOI: 10.3390/pharmaceutics12020189] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Lopez C, David-briand E, Mériadec C, Bourgaux C, Pérez J, Artzner F. Milk sphingosomes as lipid carriers for α-tocopherol in aqueous foods: thermotropic phase behaviour and morphology. Food Research International 2022. [DOI: 10.1016/j.foodres.2022.112115] [Reference Citation Analysis]
2 Cascallar M, Hurtado P, Lores S, Pensado-lópez A, Quelle-regaldie A, Sánchez L, Piñeiro R, de la Fuente M. Zebrafish as a platform to evaluate the potential of lipidic nanoemulsions for gene therapy in cancer. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1007018] [Reference Citation Analysis]
3 Yang F, Chen G. The nutritional functions of dietary sphingomyelin and its applications in food. Front Nutr 2022;9:1002574. [DOI: 10.3389/fnut.2022.1002574] [Reference Citation Analysis]
4 Homa-mlak I, Pigoń-zając D, Wawrejko P, Małecka-massalska T, Mlak R. Three Pathways of Cancer Cachexia: Inflammation, Changes in Adipose Tissue and Loss of Muscle Mass—The Role of miRNAs. JPM 2022;12:1438. [DOI: 10.3390/jpm12091438] [Reference Citation Analysis]
5 Coradduzza D, Bellu E, Congiargiu A, Pashchenko A, Amler E, Necas A, Carru C, Medici S, Maioli M. Role of Nano-miRNAs in Diagnostics and Therapeutics. Int J Mol Sci 2022;23:6836. [PMID: 35743278 DOI: 10.3390/ijms23126836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Taina-González L, de la Fuente M. The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA. Pharmaceutics 2022;14:460. [PMID: 35214191 DOI: 10.3390/pharmaceutics14020460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Bidan N, Lores S, Vanhecke A, Nicolas V, Domenichini S, López R, de la Fuente M, Mura S. Before in vivo studies: In vitro screening of sphingomyelin nanosystems using a relevant 3D multicellular pancreatic tumor spheroid model. Int J Pharm 2022;:121577. [PMID: 35167901 DOI: 10.1016/j.ijpharm.2022.121577] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Jatal R, Mendes Saraiva S, Vázquez-vázquez C, Lelievre E, Coqueret O, López-lópez R, de la Fuente M. Sphingomyelin nanosystems decorated with TSP-1 derived peptide targeting senescent cells. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Manikkath J, Jishnu PV, Wich PR, Manikkath A, Radhakrishnan R. Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis. Nanomedicine (Lond) 2022. [PMID: 35014880 DOI: 10.2217/nnm-2021-0381] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Díez-Villares S, Ramos-Docampo MA, da Silva-Candal A, Hervella P, Vázquez-Ríos AJ, Dávila-Ibáñez AB, López-López R, Iglesias-Rey R, Salgueiriño V, Fuente M. Manganese Ferrite Nanoparticles Encapsulated into Vitamin E/Sphingomyelin Nanoemulsions as Contrast Agents for High-Sensitive Magnetic Resonance Imaging. Adv Healthc Mater 2021;10:e2101019. [PMID: 34415115 DOI: 10.1002/adhm.202101019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
11 Masoumi F, Saraiva SM, Bouzo BL, López-López R, Esteller M, Díaz-Lagares Á, de la Fuente M. Modulation of Colorectal Tumor Behavior via lncRNA TP53TG1-Lipidic Nanosystem. Pharmaceutics 2021;13:1507. [PMID: 34575588 DOI: 10.3390/pharmaceutics13091507] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Díez-Villares S, Pellico J, Gómez-Lado N, Grijalvo S, Alijas S, Eritja R, Herranz F, Aguiar P, de la Fuente M. Biodistribution of 68/67Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging. Int J Nanomedicine 2021;16:5923-35. [PMID: 34475757 DOI: 10.2147/IJN.S316767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Park J, Choi J, Kim DD, Lee S, Lee B, Lee Y, Kim S, Kwon S, Noh M, Lee MO, Le QV, Oh YK. Bioactive Lipids and Their Derivatives in Biomedical Applications. Biomol Ther (Seoul) 2021;29:465-82. [PMID: 34462378 DOI: 10.4062/biomolther.2021.107] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Bouzo BL, Lores S, Jatal R, Alijas S, Alonso MJ, Conejos-Sánchez I, de la Fuente M. Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer. Sci Rep 2021;11:17213. [PMID: 34446776 DOI: 10.1038/s41598-021-96578-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
15 Ward DM, Shodeinde AB, Peppas NA. Innovations in Biomaterial Design toward Successful RNA Interference Therapy for Cancer Treatment. Adv Healthc Mater 2021;10:e2100350. [PMID: 33973393 DOI: 10.1002/adhm.202100350] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
16 Saraiva SM, Gutiérrez-Lovera C, Martínez-Val J, Lores S, Bouzo BL, Díez-Villares S, Alijas S, Pensado-López A, Vázquez-Ríos AJ, Sánchez L, de la Fuente M. Edelfosine nanoemulsions inhibit tumor growth of triple negative breast cancer in zebrafish xenograft model. Sci Rep 2021;11:9873. [PMID: 33972572 DOI: 10.1038/s41598-021-87968-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
17 Faneca H. Non-Viral Gene Delivery Systems. Pharmaceutics 2021;13:446. [PMID: 33810390 DOI: 10.3390/pharmaceutics13040446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, Xie H, Peng X, Yin W, Tao Y, Wang X. miRNA-based biomarkers, therapies, and resistance in Cancer. Int J Biol Sci 2020;16:2628-47. [PMID: 32792861 DOI: 10.7150/ijbs.47203] [Cited by in Crossref: 50] [Cited by in F6Publishing: 59] [Article Influence: 25.0] [Reference Citation Analysis]
19 Bouzo BL, Calvelo M, Martín-Pastor M, García-Fandiño R, de la Fuente M. In Vitro-In Silico Modeling Approach to Rationally Designed Simple and Versatile Drug Delivery Systems. J Phys Chem B 2020;124:5788-800. [PMID: 32525313 DOI: 10.1021/acs.jpcb.0c02731] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]